These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9550326)

  • 1. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
    Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH
    Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.
    Löffler D; Welschof M; Goldmann SF; Wölpl A
    Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
    BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
    Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
    Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
    Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
    Johnson LE; McNeel DG
    Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.
    Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P
    J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
    Geluk A; van Meijgaarden KE; Ottenhoff TH
    Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of allopeptides in context of syngeneic MHC.
    Liu Z; Braunstein NS; Suciu-Foca N
    J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
    Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
    BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
    Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
    Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.
    Liu Z; Sun YK; Xi YP; Harris P; Suciu-Foca N
    J Exp Med; 1992 Jun; 175(6):1663-8. PubMed ID: 1375267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
    Eckels DD; Geiger MJ; Sell TW; Gorski JA
    Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
    Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
    Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
    Boyle LH; Goodall JC; Gaston JS
    Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.